Table 2.
Neurotrophin | Treatment | Thermal threshold | Mechanical threshold | Electrically-evoked release of SP-LI |
---|---|---|---|---|
In vivo | ||||
NGF | Single injection | ↓ | ↓ | No effect |
NT-3 | Single injection | No effect | ↓, ↑ | No effect |
NGF | Prolonged | No effect | ↓* | ↑ |
NT-3 | Prolonged | No effect | – | ↓ |
In vitro | ||||
NGF | 1–100 ng/ml | – | – | No effect |
NT-3 | 1–100 ng/ml | – | – | ↓ |
NT-3 + naloxone | 10 ng/ml + 0.1 μm | – | – | No effect |
NT-3 + CGP 36742 | 10 ng/ml + 100 μm | – | – | ↓ |
↓, Decrease; ↑, increase; –, not measured; ↓*, Lewin et al. (1993).